We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$343M
AUM Growth
-$33M
Cap. Flow
-$39.8M
Cap. Flow %
-11.62%
Top 10 Hldgs %
29.36%
Holding
249
New
44
Increased
30
Reduced
59
Closed
53

Top Buys

Rank Stock Value
1
GIS icon
General Mills
GIS
+$9.06M
2
ACN icon
Accenture
ACN
+$8.99M
3
MDLZ icon
Mondelez International
MDLZ
+$8.31M
4
CCL icon
Carnival Corporation Ltd
CCL
+$7.88M
5
BAH icon
Booz Allen Hamilton
BAH
+$6.58M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$13M
2
HUM icon
Humana
HUM
+$12.9M
3
MCO icon
Moody's
MCO
+$12M
4
BRCM
BROADCOM CORP CL-A
BRCM
+$10.9M
5
CVS icon
CVS Health
CVS
+$10.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.59%
2 Financials 12.14%
3 Consumer Discretionary 11.15%
4 Technology 9.91%
5 Healthcare 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNC icon
176
PNC Financial Services
PNC
$101B
$2K ﹤0.01%
22
– –
PRU icon
177
Prudential Financial
PRU
$41.8B
$2K ﹤0.01%
25
– –
PSX icon
178
Phillips 66
PSX
$81.4B
$2K ﹤0.01%
24
– –
SBUX icon
179
Starbucks
SBUX
$120B
$2K ﹤0.01%
33
– –
SO icon
180
Southern Company
SO
$107B
$2K ﹤0.01%
+47
New +$2.29K
SPG icon
181
Simon Property Group
SPG
$72.3B
$2K ﹤0.01%
10
– –
TMO icon
182
Thermo Fisher Scientific
TMO
$220B
$2K ﹤0.01%
16
– –
TRV icon
183
Travelers Companies
TRV
$80.2B
$2K ﹤0.01%
+18
New +$1.97K
TXN icon
184
Texas Instruments
TXN
$261B
$2K ﹤0.01%
39
+4
+11% +$212
UNH icon
185
UnitedHealth
UNH
$370B
$2K ﹤0.01%
16
– –
USB icon
186
US Bancorp
USB
$99.6B
$2K ﹤0.01%
47
– –
V icon
187
Visa
V
$677B
$2K ﹤0.01%
26
– –
VZ icon
188
Verizon
VZ
$196B
$2K ﹤0.01%
+39
New +$1.95K
WBA
189
DELISTED
Walgreens Boots Alliance
WBA
$2K ﹤0.01%
23
– –
WFC icon
190
Wells Fargo
WFC
$264B
$2K ﹤0.01%
37
– –
WMT icon
191
Walmart Inc
WMT
$890B
$2K ﹤0.01%
+90
New +$1.97K
AGN
192
DELISTED
Allergan plc
AGN
$2K ﹤0.01%
7
– –
AET
193
DELISTED
Aetna Inc
AET
$2K ﹤0.01%
18
– –
DD
194
DELISTED
Du Pont De Nemours E I
DD
$2K ﹤0.01%
30
– –
RAI
195
DELISTED
Reynolds American Inc
RAI
$2K ﹤0.01%
42
– –
TWC
196
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$2K ﹤0.01%
10
– –
AAPL icon
197
Apple
AAPL
$4.57T
– –
-68
Closed -$2K
ABT icon
198
Abbott
ABT
$187B
– –
-48
Closed -$2K
AEO icon
199
American Eagle Outfitters
AEO
$3.01B
– –
-9,081
Closed -$141K
BA icon
200
Boeing
BA
$185B
– –
-14
Closed -$2K
6 7
8
9 10

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Contravisory Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, Contravisory Investment Management held 249 positions worth $343M, down 8.8% from $376M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Contravisory Investment Management withdrew a net $39.8M in Q1 2016, closing 53 positions and reducing 59 holdings. Its most notable exit was Gilead Sciences, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Contravisory Investment Management opened a new position in Carnival Corporation Ltd worth $8.59M.

  • Contravisory Investment Management's largest Q1 2016 buy was Carnival Corporation Ltd: 162,817 shares worth $8.59M.
  • Contravisory Investment Management added most to General Mills in Q1 2016, an estimated $9.06M increase.
  • Contravisory Investment Management's biggest Q1 2016 reduction was Bank of New York Mellon, cutting an estimated $1.05M.
  • Contravisory Investment Management fully exited Gilead Sciences in Q1 2016, selling an estimated $13M.
  • Contravisory Investment Management's ten largest holdings make up 29% of its $343M portfolio in Q1 2016.
  • Contravisory Investment Management opened 44 new positions and closed 53 in Q1 2016.
  • Contravisory Investment Management's portfolio value fell 8.8% quarter-over-quarter to $343M.

Based on Contravisory Investment Management's 13F filing for Q1 2016, filed 11 Apr 2016.